Skip to main content
OpenTrials

Clinical trial condition

TNBC, Triple Negative Breast Cancer

Explore clinical trials studying TNBC, Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

16 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

TNBC, Triple Negative Breast Cancer trial results

Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

NCT07327489

Conditions
Advanced Solid Tumors Cancer, Bladder Cancer, Breast Diseases, +64 more
Locations
  • Mercy Hospital - FTS Fort Smith, Arkansas, United States
  • Frederick Health Hospital Frederick, Maryland, United States
  • Mercy Hospital - SPG Springfield, Missouri, United States
  • Mercy Hospital - South St Louis, Missouri, United States
View Trial Details
Recruiting

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

NCT06305962

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +46 more
Locations
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • Gold Coast University Hospital Southport, Queensland, Australia
  • Cancer Research SA (CRSA) Adelaide, South Australia, Australia
View Trial Details
Recruiting

Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

NCT06682195

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Nanchang People's Hospital Nanchang, Jiangxi, China
  • Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University Hangzhou, China
  • The First Affiliated Hospital of Zhejiang University Hangzhou, China
  • Zhejiang Cancer Hospital Hangzhou, China
View all 13 locations
View Trial Details

Related conditions